We showed that treatment with tamoxifen, fulvestrant and palbociclib increased the percentage of G1-arrested (Supplementary Fig. 1a) and apoptotic (Supplementary Fig. 1b) ER+ breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.